Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Prostate Cancer

  Free Subscription


19.08.2019

1 BMC Cancer
2 Br J Cancer
1 Cancer
4 Eur Urol
3 Int J Radiat Oncol Biol Phys
6 J Urol
1 Nat Rev Urol
2 Oncogene
3 PLoS One
1 Prog Urol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMC Cancer

  1. ZHANG Y, Li F, Liu L, Jiang H, et al
    Salinomycin triggers endoplasmic reticulum stress through ATP2A3 upregulation in PC-3 cells.
    BMC Cancer. 2019;19:381.
    PubMed     Text format     Abstract available


    Br J Cancer

  2. QUINN DI, Stricker PD, Kench JG, Grogan J, et al
    p53 nuclear accumulation as an early indicator of lethal prostate cancer.
    Br J Cancer. 2019 Aug 14. pii: 10.1038/s41416-019-0549.
    PubMed     Text format     Abstract available

  3. ZHENG R, Du M, Zhang B, Xin J, et al
    Body mass index (BMI) trajectories and risk of colorectal cancer in the PLCO cohort.
    Br J Cancer. 2018 Jun 6. pii: 10.1038/s41416-018-0121.
    PubMed     Text format     Abstract available


    Cancer

  4. BARZI A, Lara PN Jr, Tsao-Wei D, Yang D, et al
    Influence of the facility caseload on the subsequent survival of men with localized prostate cancer undergoing radical prostatectomy.
    Cancer. 2019 Aug 9. doi: 10.1002/cncr.32290.
    PubMed     Text format     Abstract available


    Eur Urol

  5. VAN DER LEEST M, Cornel E, Israel B, Hendriks R, et al
    Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naive Men with Elevated Prostate-specific Antigen: A Large Prospectiv
    Eur Urol. 2019;75:570-578.
    PubMed     Text format     Abstract available

  6. MARKOWSKI MC, Boorjian SA, Burton JP, Hahn NM, et al
    The Microbiome and Genitourinary Cancer: A Collaborative Review.
    Eur Urol. 2019;75:637-646.
    PubMed     Text format     Abstract available

  7. MONTORSI F, Gandaglia G, Briganti A
    Re: Veeru Kasivisvanathan, Armando Stabile, Joana B. Neves, et al. Magnetic Resonance Imaging-targeted Biopsy Versus Systematic Biopsy in the Detection of Prostate Cancer: A Systematic Review And Meta-analysis. Eur Urol. In press. https://doi.org/10.1
    Eur Urol. 2019 Aug 7. pii: S0302-2838(19)30603.
    PubMed     Text format    

  8. KASIVISVANATHAN V, Takwoingi Y, Emberton M, Moore CM, et al
    Reply to Francesco Montorsi, Giorgio Gandaglia, Alberto Briganti's Letter to the Editor, re: Veeru Kasivisvanathan, Armando Stabile, Joana B. Neves, et al. Magnetic Resonance Imaging-targeted Biopsy Versus Systematic Biopsy in the Detection of Prostat
    Eur Urol. 2019 Aug 7. pii: S0302-2838(19)30604.
    PubMed     Text format    


    Int J Radiat Oncol Biol Phys

  9. LOGANADANE G, Coraggio G, Belkacemi Y
    In Regard to Cicchetti et al.
    Int J Radiat Oncol Biol Phys. 2019;103:776-777.
    PubMed     Text format    

  10. PARIKH RR
    Aggressive Focal Therapy.
    Int J Radiat Oncol Biol Phys. 2019;103:546.
    PubMed     Text format    

  11. CICCHETTI A, Fiorino C, Rancati T, Valdagni R, et al
    In Reply to Loganadane et al.
    Int J Radiat Oncol Biol Phys. 2019;103:777-778.
    PubMed     Text format    


    J Urol

  12. KAPLAN SA
    Re: Oxidative Damage in Patients with Benign Prostatic Hyperplasia and Prostate Cancer Co-Exposed to Phthalates and to Trace Elements.
    J Urol. 2019 Aug 12:10109701JU000057986087720.
    PubMed     Text format    

  13. TANEJA SS
    Re: Recovery of Pad-Free Continence in Elderly Men Does Not Differ from Younger Men Undergoing Robot-Assisted Radical Prostatectomy for Aggressive Prostate Cancer.
    J Urol. 2019 Aug 12:101097JU0000000000000491. doi: 10.1097/JU.0000000000000491.
    PubMed     Text format    

  14. TANEJA SS
    Re: Trend of Adverse Stage Migration in Patients Treated with Radical Prostatectomy for Localized Prostate Cancer.
    J Urol. 2019 Aug 12:10109701JU000057984426332.
    PubMed     Text format    

  15. TANEJA SS
    Re: Association of Treatment with 5alpha-Reductase Inhibitors with Time to Diagnosis and Mortality in Prostate Cancer.
    J Urol. 2019 Aug 12:10109701JU000058011614376.
    PubMed     Text format    

  16. KAPLAN SA
    Re: Association of Treatment with 5alpha-Reductase Inhibitors with Time to Diagnosis and Mortality in Prostate Cancer.
    J Urol. 2019 Aug 12:10109701JU00005798646485082.
    PubMed     Text format    

  17. RESNICK MJ
    Re: Association of Treatment with 5alpha-Reductase Inhibitors with Time to Diagnosis and Mortality in Prostate Cancer.
    J Urol. 2019 Aug 12:10109701JU00005798568009731.
    PubMed     Text format    


    Nat Rev Urol

  18. STONE L
    Different FOXA1 classes drive prostate cancer.
    Nat Rev Urol. 2019 Aug 8. pii: 10.1038/s41585-019-0223.
    PubMed     Text format    


    Oncogene

  19. COOK LM, Frieling JS, Nerlakanti N, McGuire JJ, et al
    Betaglycan drives the mesenchymal stromal cell osteogenic program and prostate cancer-induced osteogenesis.
    Oncogene. 2019 Aug 13. pii: 10.1038/s41388-019-0913.
    PubMed     Text format     Abstract available

  20. CAO S, Ma T, Ungerleider N, Roberts C, et al
    Circular RNAs add diversity to androgen receptor isoform repertoire in castration-resistant prostate cancer.
    Oncogene. 2019 Aug 13. pii: 10.1038/s41388-019-0947.
    PubMed     Text format     Abstract available


    PLoS One

  21. BISHOP MR, Huskey ALW, Hetzel J, Merner ND, et al
    A research-based gene panel to investigate breast, ovarian and prostate cancer genetic risk.
    PLoS One. 2019;14:e0220929.
    PubMed     Text format     Abstract available

  22. XU L, Lee JR, Hao S, Ling XB, et al
    Improved detection of prostate cancer using a magneto-nanosensor assay for serum circulating autoantibodies.
    PLoS One. 2019;14:e0221051.
    PubMed     Text format     Abstract available

  23. JEON JM, Kwon OK, Na AY, Sung EJ, et al
    Secretome profiling of PC3/nKR cells, a novel highly migrating prostate cancer subline derived from PC3 cells.
    PLoS One. 2019;14:e0220807.
    PubMed     Text format     Abstract available


    Prog Urol

  24. AOUN F, Albisinni S, Biaou I, Peltier A, et al
    Salvage Hemiablation High Intensity Focused Ultrasound for unilateral radio-recurrent prostate cancer.
    Prog Urol. 2019 Aug 7. pii: S1166-7087(19)30155.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: